Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2022-07-12 00:00:00 ET · period of report 2022-07-08 · accession 0001737287-22-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-12 | 2022-07-08 | ALLO | Mayo Stephen | Dir | A - Grant | $0.00 | +35.3K | 35.3K | New | $0 |
| D | 2022-07-12 | 2022-07-08 | ALLO | Mayo Stephen | Dir | A - Grant | $0.00 | +54.5K | 54.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-08 | A | A | 35,328 | $0.00 | 35,328 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-07-08 | A | A | 54,487 | $0.00 | 54,487 | D | $12.03 · — to 2032-07-08 | 54,487 Common Stock | (F1) 1. The shares subject to the stock option shall vest in a series of 36 successive equal installments measured from the date of grant. |